Publications
3 shownCombined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
A combination of dabrafenib and trametinib, as compared with dabrafenib alone, improved the rate of progression-free survival in previously untreated patients who had metastatic...
Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study
Purpose To compare fotemustine and dacarbazine (DTIC) in terms of overall response rate (ORR) as primary end-point and overall survival, duration of responses, time to progressi...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 4,877
- Institution
- Elbe Kliniken Stade-Buxtehude
External Links
Identifiers
- ORCID
- 0000-0002-7328-7407
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.